Xuehang Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xuehang Jin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Dan Zhu
Department of Respiration and Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, China
2 shared publications - Hui Chen
Department of Respiratory and Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang Province, China
2 shared publications - Lvjun Zhang
Department of Respiration and Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province, China
2 shared publications Chiqing Ying
Department of Respiration and Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, China
1 shared publication- Chiqing Ying
Department of Respiration, Jinhua Municipal Central Hospital, Jinhua, China
1 shared publication Jiepeng Tong
State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang 310000, People's Republic of China
1 shared publication
Latest Publications
- Open Access
Pulmonary infection caused by Talaromyces amestolkiae
The results of metagenomic next-generation sequencing.
Open AccessPulmonary infection caused by Talaromyces amestolkiae
The results of metagenomic next-generation sequencing.
- Open Access
- 27 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (39) , e39807
Cryptogenic organizing pneumonia caused by solanine: A case report
Rationale: Cryptogenic organizing pneumonia (COP) is a type of pneumonia with unknown cause, presenting with symptoms like dyspnea, fever, and cough. Solanine poisoning can cause symptoms like increased heart rate, rapid breathing, sore throat, diarrhea, vomiting, and fever, but there are no known cases of it causing COP. Patient concerns: A 43-year-old man had a dry cough, worse at night, with phlegm and chest tightness after eating sprouted potatoes. No history of surgeries or family medical issues. Diagnosis: Laboratory tests and metagenomic next-generation sequencing of bronchoalveolar lavage fluid from the bilateral lower lobes did not yield a definitive pathogen. Further evaluation included testing for vasculitis-associated antibodies and rheumatologic immune markers for myositis spectra to rule out connective tissue disease-associated interstitial lung disease as the etiology of organizing pneumonia. As a result, the final diagnosis was determined to be COP. Interventions: The patient received glucocorticoid therapy and oxygen therapy, and responded well to the treatment. Outcomes: On the 10th day of hospitalization, the patient was discharged with success. A follow-up chest CT conducted over a month later revealed that the lesions in both lungs had essentially resolved, with only minor residual fibrotic changes present. Lessons: Regularly monitoring disease progression is crucial for patients with solanine poisoning who have pulmonary symptoms. Promptly conducting chest CT scans and bronchoscopy is advised to check for any infections. It is also important to rule out pneumonia related to connective tissue disease-associated interstitial lung disease and provide appropriate treatment promptly.
- 27 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (39) , e39807
Open AccessCryptogenic organizing pneumonia caused by solanine: A case report
Rationale: Cryptogenic organizing pneumonia (COP) is a type of pneumonia with unknown cause, presenting with symptoms like dyspnea, fever, and cough. Solanine poisoning can cause symptoms like increased heart rate, rapid breathing, sore throat, diarrhea, vomiting, and fever, but there are no known cases of it causing COP. Patient concerns: A 43-year-old man had a dry cough, worse at night, with phlegm and chest tightness after eating sprouted potatoes. No history of surgeries or family medical issues. Diagnosis: Laboratory tests and metagenomic next-generation sequencing of bronchoalveolar lavage fluid from the bilateral lower lobes did not yield a definitive pathogen. Further evaluation included testing for vasculitis-associated antibodies and rheumatologic immune markers for myositis spectra to rule out connective tissue disease-associated interstitial lung disease as the etiology of organizing pneumonia. As a result, the final diagnosis was determined to be COP. Interventions: The patient received glucocorticoid therapy and oxygen therapy, and responded well to the treatment. Outcomes: On the 10th day of hospitalization, the patient was discharged with success. A follow-up chest CT conducted over a month later revealed that the lesions in both lungs had essentially resolved, with only minor residual fibrotic changes present. Lessons: Regularly monitoring disease progression is crucial for patients with solanine poisoning who have pulmonary symptoms. Promptly conducting chest CT scans and bronchoscopy is advised to check for any infections. It is also important to rule out pneumonia related to connective tissue disease-associated interstitial lung disease and provide appropriate treatment promptly.
- Open Access
- 1 October 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 130, 110556
Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells
- 1 October 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 130, 110556
Open AccessIdentification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells